Recent advances in pain management in palliative care

1994 Twycross, 1996, A survey of pain in patients with advanced cancer, J Pain Symptom Manage, 12, 273, 10.1016/S0885-3924(96)00149-2 Zech, 1995, Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study, Pain, 63, 65, 10.1016/0304-3959(95)00017-M Welsh, J, Brewster, D, Cornbleet, M, A Scottish national audit of prevalence of pain in patients with active cancer, April 2001 Addington-Hall, 1995, Dying from cancer: results of a national population-based investigation, Palliat Med, 9, 295, 10.1177/026921639500900404 2000 Hanks, 2001, Morphine and alternative opioids in cancer pain: the EAPC recommendations, Br J Cancer, 84, 587, 10.1054/bjoc.2001.1680 Galer, 1993, Individual variability in the response to different opioids: report of five cases, Pain, 52, 137 Mercadante, 1999, Opioid rotation for cancer pain: rationale and clinical aspects, Cancer, 86, 1856, 10.1002/(SICI)1097-0142(19991101)86:9<1856::AID-CNCR30>3.0.CO;2-G Shah, 2001, Oxycodone: a review of the literature, Eur J Palliat Care, 8, 93 Lee, 2001, Retrospective study of the use of hydromorphone in palliative care patients with normal and abnormal urea and creatinine, Palliat Med, 15, 26, 10.1191/026921601669626431 Ripamonti, 1997, An update on the clinical use of methadone for cancer pain, Pain, 70, 109, 10.1016/S0304-3959(96)03286-1 Jenkins, 1999, Nonsteroidal anti-inflammatory drugs as adjuvant analgesics in cancer patients, Palliat Med, 13, 183, 10.1191/026921699666671383 Silverstein, 2000, Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study, JAMA, 284, 1247, 10.1001/jama.284.10.1247 Whelton, 2000, Cyclooxygenase-2-specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients, Am J Ther, 8, 85, 10.1097/00045391-200103000-00003 Backonja, 1998, Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial, JAMA, 280, 1831, 10.1001/jama.280.21.1831 Rowbotham, 1998, Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial, JAMA, 280, 1837, 10.1001/jama.280.21.1837 Caraceni, 1999, Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain, J Pain Symptom Manage, 17, 441, 10.1016/S0885-3924(99)00033-0 Chandler, 2000, Gabapentin, an adjuvant treatment for neuropathic pain in a cancer hospital, J Pain Symptom Manage, 20, 82, 10.1016/S0885-3924(00)00166-4 Mercadante, 1996, Ketamine in cancer pain: an update, Palliat Med, 10, 225 Mercadante, 2000, Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study, J Pain Symptom Manage, 20, 246, 10.1016/S0885-3924(00)00194-9 Mitchell, A, Graham, J, Fallon, M, Does ketamine improve limb pain?, March 2001 Rogers, 2000, Cellular and molecular mechanisms of action of bisphosphonates, Cancer, 88, 2961, 10.1002/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L Mannix, 2000, Using bisphosphonates to control the pain of bone metastases: evidence-based guidelines for palliative care, Palliat Med, 14, 455, 10.1191/026921600701536372 Berenson, 2001, Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases, Cancer, 91, 1191, 10.1002/1097-0142(20010401)91:7<1191::AID-CNCR1119>3.0.CO;2-0 Taylor, 1996, Venlafaxine hydrochloride and chronic pain, West J Med, 165, 147 Pernia, 2000, Venlafaxine for the treatment of neuropathic pain, J Pain Symptom Manage, 19, 408, 10.1016/S0885-3924(00)00151-2 Meng, 1998, An analgesia circuit activated by cannabinoids, Nature, 395, 381, 10.1038/26481 Notcutt, W, Miller, R, Newport, S, Price, M, Samson, C, Simmons, S, Study of cannabis based medicinal extracts in chronic pain, Cannabidiol reduces the psychoactive effects of D9-Tetrahydrocannibanol, March 2001 Nichols, 1996, Antiallodynic effects of a CCKB antagonist in rats with nerve ligation injury: role of endogenous enkephalins, Neurosci Lett, 215, 161, 10.1016/0304-3940(96)12964-5 Simpson, K, Taverner, T, Rowbotham, D, J, Edwards, N, Parnacott, S, Leng, M, Trotman, I, The CCK A antagonist devazepide (Devacade) as an adjunct to strong opioids in the management of patients with neuropathic pain, March 2001